Protecting healthcare and patient pathways from infection and antimicrobial resistance
- PMID: 39374953
- PMCID: PMC11450933
- DOI: 10.1136/bmj-2023-077927
Protecting healthcare and patient pathways from infection and antimicrobial resistance
Abstract
Innovative whole system approaches to integrate research and novel technologies within patient pathways are needed to target antibiotic use, minimise healthcare associated infections, and adapt to novel pathogens, write Derek Cocker and colleagues
Conflict of interest statement
Competing interests: We have read and understood BMJ policy on declaration of interests and have no conflicts of interest to declare. Provenance and peer review: Commissioned; externally peer reviewed.
References
-
- Cassini A, Plachouras D, Eckmanns T, et al. Burden of six healthcare-associated infections on European population health: estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study. PLoS Med 2016;13:e1002150. 10.1371/journal.pmed.1002150 - DOI - PMC - PubMed
-
- Plachouras D, Kärki T, Hansen S, et al. Point Prevalence Survey Study Group . Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017. Euro Surveill 2018;23:1800393. 10.2807/1560-7917.ES.23.46.1800393 - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical